Identifying Regulators of Degeneration due to Defective Mitochondrial DNA

NIH RePORTER · NIH · R01 · $757,254 · view on reporter.nih.gov ↗

Abstract

Program Director/Principal Investigator (Last, First, Middle): Guo, Ming Project Summary/Abstract Neurodegenerative disorders affect 50% of the population over the age of 85. The strongest risk factor for most neurodegenerative disorders including Alzheimer’s disease is aging. Accumulation of mitochondrial DNA (mtDNA) mutations leads to cellular dysfunction, contributes to human aging and can be observed in age-related diseases such as Alzheimer’s disease, Parkinson’s disease and sarcopenia. Strategies that reduce the mtDNA deleterious mutation load and improve mtDNA quality control are likely to reduce the age-related pathologies of neurodegenerative diseases. We have generated unique transgenic tools in living Drosophila melanogaster post-mitotic tissues that contain engineered mixed mtDNA deletion mutations (deleterious heteroplasmy models). We aim to use these systems and system biology approaches to identify genes and compounds that lead to suppression or enhancement of the mitochondrial DNA quality control. OMB No. 0925-0001/0002 (Rev. 03/16 Approved Through 10/31/2018) Page Continuation Format Page

Key facts

NIH application ID
10450087
Project number
5R01AG061405-05
Recipient
UNIVERSITY OF CALIFORNIA LOS ANGELES
Principal Investigator
MING GUO
Activity code
R01
Funding institute
NIH
Fiscal year
2022
Award amount
$757,254
Award type
5
Project period
2018-09-30 → 2025-02-28